January 16, 2013 — Americans' cardiovascular health varies greatly from state to state, according to new research in the Journal of the American Heart Association (JAHA). The study is the first to assess cardiovascular health at the state level.
The U.S. Food and Drug Administration (FDA) has cleared St. Jude Medical’s new version of its Merlin.net Patient Care Network (PCN). The secure, Internet-based remote care system is for patients with implanted implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices and pacemakers.
January 16, 2013 — Medtronic’s CareLink Express service is a remote monitoring system that enables clinicians in healthcare facilities to quickly obtain data regarding the status of Medtronic implanted cardiac devices, facilitating faster treatment decisions.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
January 16, 2013 — Just weeks after the Food and Drug Administration (FDA) approved Cook Medical’s Zilver PTX drug-eluting peripheral stent, Riverside Methodist Hospital in Columbus, Ohio, has treated the first patient with the device as part of Cook’s U.S. commercial launch.
Biotronik announced the first U.S. implant of their Pulsar-18 self expanding stent in the BIOFLEX-I IDE clinical trial. Carlos Mena of Yale University Medical Center performed the procedure.
Covidien announced the completion of enrollment in its DEFINITIVE AR (anti-restenosis) study. As the third study in the DEFINITIVE trial series, this randomized pilot is designed to address the challenge of preventing restenosis (re-narrowing of a blood vessel following treatment), a common occurrence in patients with peripheral artery disease (PAD).
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the U.S. market for diagnostic imaging equipment servicing will grow slowly to a value of just over $2.78 billion by 2017. Increases in diagnostic imaging system sales and the installed base will be counterbal
McKesson released its Cardiology 13.0 system, which offers a single database solution for cardiac and peripheral catheterization, hemodynamic monitoring, electrophysiology (EP), echocardiography, vascular ultrasound, nuclear cardiology and electrocardiogram (ECG), ECG stress and Holter management. Data entered at any point-of-care flows into the electronic health record (EHR) without the need for potentially cumbersome interfaces or redundant documentation. This latest release is designed to boost clinical efficiencies and reduce operational costs.
April 27, 2012 — GE Healthcare, a unit of General Electric Company, announced the U.S. Food and Drug Administration (FDA) clearance and availability of the latest version of its Vivid E9 cardiovascular ultrasound system. The Vivid E9 Breakthrough 2012 (BT12) includes a 4-D transducer for transesophageal echocardiography (TEE) and also provides innovative tools designed to help improve workflow efficiency through simplified image acquisition, intuitive navigation and advanced, yet easy to use, quantification.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
The Detroit Medical Center (DMC) announced that a team of heart specialists at its Cardiovascular Institute (CVI) has successfully conducted the Midwest's first-ever "robotic-assisted" coronary revascularization to relieve heart artery blockages. The successful implementation of the pioneering new treatment procedure — unique in Michigan and so far performed at only three institutions in the United States — means that DMC heart care patients now have access to the world's most advanced treatment method for relieving blockages in heart arteries, said CVI President Theodore L. Schreiber, M.D.
January 11, 2013 — Guided Interventions LLC, a startup company developing new, easier to use fractional flow reserve (FFR) a product to help cardiologists better assess the physiological impact of coronary artery blockages, has received a $250,000 investment commitment from nonprofit venture development organization JumpStart Inc.
August 20, 2012 — Zoll Medical Corp., a manufacturer of medical devices and related software solutions, announced that physicians at all of the 17 “Honor Roll” hospitals and all of the 50 “Best Cardiology and Heart Surgery” hospitals designated by U.S. News and World Report for 2012-2013 have prescribed the Zoll LifeVest Wearable Defibrillator for patients.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Toshiba has unveiled a 640-slice computed tomography (CT) scanner at the 2012 annual meeting of the Radiological Society of North America (RSNA). The Aquilion One Vision Edition is equipped with a gantry rotation of 0.275 seconds, a 100 kw generator and 320 detector rows (640 unique slices) covering 16 cm in a single rotation, with the industry’s thinnest slices at 500 microns (0.5 mm).
Zoll’s RescueNet 12-Lead is a free and versatile transmission system that allows healthcare providers to receive and ...
Angioslide announced the closing of $6.3 million financing led by new investor TriVentures. In addition Biostar joined returning investors Viola Partners, Agate and XT Investments to complete the round.